Lenalidomide use in multiple myeloma.
2020
e14045Background: For patients with multiple myeloma (MM), lenalidomide’s (LEN) received its first FDA approval for use in combination with dexamethasone (DEX) for second-line treatment in 2006, an...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI